Back
Protara Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
TARA
Protara Therapeutics, Inc.
Last Price:
$5.56
Seasonality Move:
27.06%
7 Day Trial
ALL ACCESS PASS
$
7
Protara Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protara Therapeutics, Inc. has on average historically risen by 2.2% based on the past 11 years of stock performance.
-
Protara Therapeutics, Inc. has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
-
Is Protara Therapeutics, Inc. Stock Undervalued?The current Protara Therapeutics, Inc. [TARA] share price is $5.49. The Score for TARA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
TARA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Protara Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protara Therapeutics, Inc. has on average historically risen by 2.2% based on the past 11 years of stock performance.
Protara Therapeutics, Inc. Stock Rating
Buy
55
Protara Therapeutics, Inc. (TARA)
is a Buy
Is Protara Therapeutics, Inc. overpriced?
-
Protara Therapeutics, Inc. has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
Protara Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protaratx.com
52-Week Data
52-Week High:
7.82
52-Week Low:
2.77
Prediction Charts
Market Cap:
211.8M
Price in USD:
5.49
Volume:
235.1K
Beta:
1.23
Technical Analysis
SMA50:
5.69
SMA100:
4.66
SMA200:
4.09
52-Wk Change:
6.19%
Stock Predictions
-
Is Protara Therapeutics, Inc. stock public?Yes, Protara Therapeutics, Inc. is a publicly traded company.
-
What is the Protara Therapeutics, Inc. stock quote today?The Protara Therapeutics, Inc. stock price is 5.49 USD today.
-
How to buy Protara Therapeutics, Inc. stock online?You can buy Protara Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-8 | 5.62 | 5.72 | 5.81 | 5.56 |
| Dec-9 | 5.67 | 5.74 | 5.75 | 5.55 |
| Dec-10 | 5.80 | 5.74 | 5.80 | 5.55 |
| Dec-11 | 5.70 | 6.01 | 6.37 | 5.70 |
| Dec-12 | 6.06 | 5.70 | 6.13 | 5.52 |
| Dec-15 | 5.75 | 5.50 | 5.80 | 5.46 |
| Dec-16 | 5.55 | 5.42 | 5.62 | 5.40 |
| Dec-17 | 5.44 | 5.35 | 5.55 | 5.31 |
| Dec-18 | 5.42 | 5.18 | 5.49 | 5.03 |
| Dec-19 | 5.21 | 5.27 | 5.40 | 5.11 |
| Dec-22 | 5.28 | 5.41 | 5.49 | 5.28 |
| Dec-23 | 5.36 | 5.37 | 5.49 | 5.26 |
| Dec-24 | 5.37 | 5.49 | 5.50 | 5.36 |
| Dec-26 | 5.49 | 5.55 | 5.56 | 5.35 |
Protara Therapeutics, Inc. Earnings
Protara Therapeutics, Inc. Earnings Report: Per Share Protara Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protara Therapeutics, Inc. Forecast Revenue Growth
Protara Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protara Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and a decrease next year of $0.10 per share.
* Protara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.